ONCAlert | 2017 NANETS Symposium

Dr. Van Tine Discusses the Development of Olaratumab in Sarcoma

Brian Van Tine, MD, PhD
Published Online:3:46 PM, Wed December 6, 2017

Brian Van Tine, MD, PhD, assistant professor, Washington University School of Medicine, discusses the development of olaratumab (Lartruvo) in soft tissue sarcoma.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.